---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-014775"
form_type: "8-K"
ticker: "LSTA"
cik: "0000320017"
company_name: "LISATA THERAPEUTICS, INC."
filed_at: "2026-04-15T23:59:59+00:00"
generated_at: "2026-05-15T06:12:52.231840+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Lisata acquisition in limbo: Kuva Labs delays tender offer, seeks new financing

## Summary
- Kuva Labs has not yet commenced tender offer for Lisata; deadline extended from April 3 to April 13, 2026.
- Kuva seeking alternative financing on more favorable terms; will launch tender only after financing finalized.
- Lisata in discussions with Kuva regarding financing and timing; no assurance of commencement or deal completion.
- Potential termination of Merger Agreement if tender not commenced; risks include termination fees and litigation.

## SEC filing metadata
- accession: 0001140361-26-014775
- form_type: 8-K
- ticker: LSTA
- cik: 0000320017
- company_name: LISATA THERAPEUTICS, INC.
- filed_at: 2026-04-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/320017/000114036126014775/0001140361-26-014775-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/320017/000114036126014775/ef20070652_form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-014775
- JSON: https://secwatch.observer/filing/0001140361-26-014775.json
- Plain text: https://secwatch.observer/filing/0001140361-26-014775.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.